EARNINGS PER SHARE AND EQUITY - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
Mar. 31, 2024	Mar. 31, 2023
Earnings Per Share [Abstract]
Antidilutive shares (in shares)	7,196,869	1,647,839
Weighted average remaining contractual term, exercisable	6 years 3 months 18 days
Fair value of warrants	$ 21.0

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration